Skip to main content
. 2020 Oct 26;36(2):430–437. doi: 10.1007/s11606-020-06276-1

Table 1.

Characteristics of Patients Receiving Short-Acting Opioid Prescriptions and of Their Providers at the Two Study Sites, January 1, 2015–December 31, 2018

N (%)1
Weill Cornell Medicine Institute for Family Health
Total patients 18,218 (100.0) 3895 (100.0)
  Number female 9139 (49.4) 2705 (68.6)
  Number white 3562 (19.2)4 1639 (41.6)
  Number commercially insured2 7638 (77.2) 2524 (25.6)
  Number Medicaid 149 (1.5) 4261 (44.2)
  Number Medicare 2106 (21.3) 2866 (29.0)
  Number uninsured 0 (0.0) 110 (1.0)
Total prescribers 585 (100.0) 236 (100.0)
  Attending physician (MD or DO) 417 (71.3) 192 (81.4)
  Resident or fellow 13 (2.2) 45 (19.1)
  Advanced practice nurse (FNP/ANP) or PA 103 (17.6) 39 (16.53)
Prescriber specialty
  Internal medicine3 72 (12.31) 4 (1.7)
  Family practice 0 (0) 162 (68.6)
  Other medical 242 (41.38) 70 (26.9)
  Surgical 271 (46.32) 0 (0)
Total new short-acting opioid prescriptions 18,518 (100.0) 3943 (100.0)
  Internal medicine 1666 (9.0) 160 (4.1)
  Family practice 0 (0) 3413 (86.5)
  Other medical 6170 (32.3) 370 (9.4)
  Surgical 10,682 (57.7) 0 (0)

1Counts of patients and providers reflect unique patients and providers even though each patient and provider could appear in the data set more than once

2For simplicity, the distribution of insurance types reflects the last covered visit in 2018

3At the academic medical center, “internal medicine” includes primary care as well as internal medicine subspecialties such as cardiology and endocrinology. “Other medical” includes emergency medicine, rehabilitation medicine and physical therapy, psychiatry, dialysis, and (non-interventional) radiology

4At the academic medical center, 59.9% of patients (11,091) had unknown race